Janney Capital Management LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 10,561 shares of the company's stock, valued at approximately $369,000.
Several other large investors have also recently added to or reduced their stakes in the stock. Johnson Investment Counsel Inc. increased its holdings in Option Care Health by 3.7% in the 1st quarter. Johnson Investment Counsel Inc. now owns 87,691 shares of the company's stock valued at $3,065,000 after purchasing an additional 3,120 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in Option Care Health by 2.7% in the 1st quarter. State of Alaska Department of Revenue now owns 19,931 shares of the company's stock valued at $696,000 after purchasing an additional 525 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in Option Care Health by 25.7% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company's stock valued at $289,000 after purchasing an additional 1,691 shares in the last quarter. SG Americas Securities LLC acquired a new stake in Option Care Health in the 1st quarter valued at $743,000. Finally, GAMMA Investing LLC grew its stake in shares of Option Care Health by 307.1% during the first quarter. GAMMA Investing LLC now owns 3,192 shares of the company's stock valued at $112,000 after acquiring an additional 2,408 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.
Option Care Health Stock Performance
Shares of OPCH stock opened at $31.56 on Friday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.02 and a current ratio of 1.54. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The company's 50-day simple moving average is $32.08 and its 200-day simple moving average is $30.48. The stock has a market capitalization of $5.17 billion, a price-to-earnings ratio of 25.45, a PEG ratio of 1.91 and a beta of 0.74.
Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The business had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter last year, the company posted $0.26 earnings per share. The company's quarterly revenue was up 16.3% compared to the same quarter last year. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the company. JMP Securities restated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Wednesday. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. JPMorgan Chase & Co. raised their target price on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Finally, UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $35.50.
Check Out Our Latest Analysis on OPCH
Option Care Health Profile
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
